0.0549 USD
-0.01 (-15.15%)
0.0579 USD
+0 (+5.46%)
ChartMill assigns a Buy % Consensus number of 40% to ADAP. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 0.28. This target is 410.93% above the current price.
ADAP was analyzed by 6 analysts. The buy percentage consensus is at 40. So analysts seem to be rather negative about ADAP.
In the last month the buy percentage fell by 7 points. So the trust of analysts is decreasing.
ADAP was analyzed by 6 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-07-29 | HC Wainwright & Co. | Downgrade | Buy -> Neutral |
| 2025-06-26 | Mizuho | Downgrade | Outperform -> Neutral |
| 2025-05-14 | Barclays | Maintains | Underweight -> Underweight |
| 2025-05-14 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2025-04-01 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-03-26 | Guggenheim | Maintains | Buy -> Buy |
| 2025-03-21 | ScotiaBank | Maintains | Sector Outperform -> Sector Outperform |
| 2025-03-21 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2024-11-27 | Mizuho | Maintains | Outperform -> Outperform |
| 2024-11-19 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-11-15 | Guggenheim | Maintains | Buy -> Buy |
| 2024-11-14 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-08-13 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-08-05 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-07-30 | HC Wainwright & Co. | Initiate | Buy |
| 2024-05-30 | ScotiaBank | Initiate | Sector Outperform |
| 2024-05-17 | Mizuho | Maintains | Buy -> Buy |
| 2023-08-10 | EF Hutton | Reiterate | Buy -> Buy |
| 2023-08-10 | Barclays | Maintains | Underweight -> Underweight |
| 2023-06-05 | EF Hutton | Reiterate | Buy -> Buy |
| 2023-06-02 | EF Hutton | Reiterate | Buy |
| 2023-05-26 | EF Hutton | Reiterate | Buy |
| 2023-04-17 | EF Hutton | Reiterate | Buy |
| 2023-04-11 | EF Hutton | Reiterate | Buy |
| 2023-03-06 | EF Hutton | Reiterate | Buy |
| 2023-01-05 | EF Hutton | Initiate | Buy |
| 2023-01-03 | Guggenheim | Upgrade | Neutral -> Buy |
| 2022-11-14 | Wells Fargo | Maintains | Equal-Weight |
| 2022-11-09 | Mizuho | Upgrade | Neutral -> Buy |
| 2022-10-04 | Wells Fargo | Maintains | Equal-Weight |
ADAPTIMMUNE THERAPEUTICS-ADR / ADAP FAQ
What is the price target for ADAP stock?
6 analysts have analysed ADAP and the average price target is 0.28 USD. This implies a price increase of 410.93% is expected in the next year compared to the current price of 0.0549.
How do analysts rate ADAPTIMMUNE THERAPEUTICS-ADR (ADAP)?
The consensus rating for ADAPTIMMUNE THERAPEUTICS-ADR (ADAP) is 40 / 100 . This indicates that analysts generally have a neutral outlook on the stock.
Can you provide the analyst count for ADAPTIMMUNE THERAPEUTICS-ADR stock?
The number of analysts covering ADAPTIMMUNE THERAPEUTICS-ADR (ADAP) is 6.